During Thursday’s trading session, the shares of a company engaged in manufacturing a wide range of oncology (anti-cancer) drugs in India surged nearly 7.2 percent to Rs. 2,088.95 on NSE, after the company announced to migrate from the SME platform of NSE to the main board.  With a market cap of Rs. 1,913.2 crores, at … Continue reading Pharma stock jumps 7% after it plans to list on BSE and NSE mainboard